Researchers from National University Hospital (NUH), National Cancer Institute, Singapore (NCIS), the Yong Loo Lin School of Medicine, National University of Singapore, Duke-NUS Medical School and ...

Three-year outcomes of two phase II studies of adjuvant chemotherapy with S-1 plus oxaliplatin or capecitabine plus oxaliplatin in patients with stage III gastric cancer after D2 gastrectomy.

Metastatic colorectal adenocarcinoma (mCRC) with proficient mismatch repair (pMMR) is associated with poor response to cytotoxic chemotherapy in the refractory setting. In patients with peritoneal ...

Among the key speakers was Associate Professor Johnny Ong, Head and Senior Consultant of the Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT) at the National Cancer Cen ...

Neoantigen (tumor-specific antigen) mRNA-based vaccines induce progenitor‑exhausted T cells that support anti‑PD‑1 therapy, leading to enhanced antitumor efficacy against gastric cancer, which has ...

As cancer continues to rise across South Asia, global collaboration and advances in surgical oncology are offering new hope for patients.